NCT06593574

Brief Summary

The purpose of this clinical trial is to evaluate the effectiveness and safety of this spinal robot in assisting doctors to perform laminectomy in spinal surgery under the premise of ensuring the safety of the subjects and ensuring the scientific nature of the clinical trial.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
26 days until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

October 22, 2024

Status Verified

September 1, 2024

Enrollment Period

1.2 years

First QC Date

September 9, 2024

Last Update Submit

October 20, 2024

Conditions

Keywords

Spinal robotLaminectomy

Outcome Measures

Primary Outcomes (1)

  • Accuracy rate of laminectomy

    According to the classification criteria for the accuracy of laminectomy proposed by Zhuofu Li, grade A indicates that the pre-planned cutting lines are basically located in the actual cutting groove or that the maximum distance between them is \<1mm; Grade B indicates that the maximum distance between the pre-planned cutting line and the actual cutting groove is 1 to 2mm. Grade C indicates a maximum distance of \>2 mm between the two. Grades A and B are acceptable. The percentage of A+B in the total number of planned boundaries was counted as the accuracy rate of laminectomy.

    Immediately after the intraoperative laminectomy procedure

Secondary Outcomes (7)

  • Success rate of laminectomy

    Immediately after the intraoperative laminectomy procedure

  • Improvement rate of Japanese Orthopaedic Society (JOA) Score

    JOA scores were used to evaluate experimental and control subjects before and one month after surgery.

  • Visual analogue scale (VAS)

    Before and one month after the operation

  • Laminectomy time per spinal segment

    Immediately after surgery.

  • Total laminectomy time

    Immediately after surgery.

  • +2 more secondary outcomes

Study Arms (2)

Robotic laminectomy group

EXPERIMENTAL

The laminectomy is performed with the assistance of a robot

Procedure: Robotic laminectomy

Manual laminectomy group

ACTIVE COMPARATOR

The laminectomy is performed by the surgeon without the assistance of a robot

Procedure: Traditional laminectomy

Interventions

Surgical robots are used to assist with laminectomy

Robotic laminectomy group

Instead of relying on a surgical robot, doctors perform the laminectomy themselves with an ultrasonic osteotome

Manual laminectomy group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18-80 years old (including 18 and 80 years old), regardless of gender;
  • Patients with complete clinical data, willing and able to sign informed consent;
  • Patients with lumbar disc herniation, lumbar spinal stenosis, lumbar instability, lumbar spondylolisthesis, and lumbar fracture meet the indications for spinal laminectomy and undergoing open surgery;
  • Patients with lumbar disc herniation, lumbar spinal stenosis, or lumbar instability have one of the following:
  • It was not effective after 3 months of conservative treatment
  • Symptoms seriously affect the quality of life
  • cauda equina nerve injury
  • Lumbar spondylolisthesis occurs in one of the following:
  • Symptoms of II° and below slip were not relieved by non-surgical treatment
  • Lumbar spondylolisthesis III° and above
  • Symptoms of lumbar spinal stenosis
  • The TLISS score of lumbar spine fracture is greater than or equal to 4 points.

You may not qualify if:

  • Patients who are not suitable for robot-assisted surgery;
  • Patients with existing implants in or near the vertebral body of the lesion;
  • Patients whose vertebral lamina bone tissue of the focal vertebra or adjacent vertebra has been removed;
  • Pregnant and lactating female patients;
  • the subject is unwilling or unable to restrict activities or follow medical advice;
  • Patients with infection near the focal area;
  • The patient is mentally incapable or unable to understand the requirements for participating in the study;
  • The patient is critically ill, the expected survival period is not more than 2 years, and it is difficult to make an accurate assessment of the effectiveness and safety of the device;
  • Patients with coagulation dysfunction;
  • Other researchers did not consider it suitable for admission.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Peking University Third Hospital

Beijing, 100101, China

RECRUITING

Third Affiliated hospital of Southern medical university

Guangzhou, China

NOT YET RECRUITING

Zhejiang Provincial Hospital of Chinese Medicine

Hangzhou, China

NOT YET RECRUITING

MeSH Terms

Conditions

Spinal StenosisIntervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Weishi Li, M.D.

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Zhuofu Li, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 19, 2024

Study Start

October 15, 2024

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

October 22, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations